CMNDCaleminderCMND info
$1.22info1.67%24h
Global rank33071
Market cap$2.07M
Change 7d-3.71%
YTD Performance-57.79%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings-$5.98M
Dividend yield-
Main Sector
Healthcare

Caleminder (CMND) Stock Overview

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company has a collaboration with SciSparc Ltd. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

CMND Stock Information

Symbol
CMND
Address
1220 West 6th AvenueVancouver, BC V6H 1A5Canada
Founded
-
Trading hours
-
Website
https://www.clearmindmedicine.com
Country
🇨🇦 Canada
Phone Number
604 260 1566

Caleminder (CMND) Price Chart

-
Value:-

Caleminder Overview: Key Details and Summary

Stock data
2023
Change
Price
$1.22
N/A
Market Cap
$2.07M
N/A
Shares Outstanding
1.69M
3807.21%
Employees
0
N/A
Earnings
2023
Change
Revenue
$0
N/A
Earnings
-$5.98M
N/A
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org